FAKTOR-OPTIONSSCHEIN - ORION B | Real-time Bid/Ask 09:04:58 2024-07-16 am EDT | ||
| 27.77 EUR / 27.98 EUR | -4.08% |
|
| Current month | +20.28% | ||
| 1 month | +62.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ORION OYJ
Latest news about ORION OYJ
More news
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 27.25 | -6.23% |
| 24-07-15 | 29.06 | +3.71% |
| 24-07-12 | 28.02 | -0.78% |
| 24-07-11 | 28.24 | +3.29% |
| 24-07-10 | 27.34 | -6.14% |
Delayed Quote Börse Stuttgart
Last update July 16, 2024 at 06:19 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | ORION OYJ |
| Issuer | Morgan Stanley |
| WKN | MG23W8 |
| ISIN | DE000MG23W88 |
| Date issued | 2024-04-10 |
| Strike | 34.07 € |
| Maturity | Unlimited |
| Parity | 0.25 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 31.62 € |
|---|---|
| Lowest since issue | 8.42 € |
| Spread | 0.21 € |
| Spread % | 0.76% |
Company Profile
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (43.4%);
- patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;
- animal health products (8.7%);
- pharmaceutical ingredients and outsourcing services (6.2%).
Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%).
Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Sector
-
Consensus: Orion Oyj
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
40.88
EUR
Average target price
38.6
EUR
Spread / Average Target
-5.58%
- Stock Market
- Certificates
- Certificat
